Porton Biopharma are one of the United Kingdom’s leading pharmaceutical companies. They develop and manufacture lifesaving bio-pharmaceutical therapeutics and vaccines.
Porton Biopharma mission is to protect patients’ health through the quality-assured development and production of biopharmaceuticals. They develop new vaccines, therapeutic proteins and enzyme products, and also manufacture their own licensed biopharmaceutical products.
EAMS Group will be helping Porton Biopharma with their investment into their EAM system and processes and will be undertaking a digital diagnostic and training to ensure their investment and digital journey is realised.